Observed arrival · 2026-09-06

Value99 Watches the FDA So You Don't Have To

value99.net Observed source

Editorial interest 78/100 Selection signal · not a rating of the site

A subscription alert service monitors FDA drug approvals, device approvals, and press announcements, then emails matched updates with plain-language summaries and market context.

Landing page captured for the 2026-09-06 issue.

Field notes

Value99 combines three FDA-related source categories—drug approvals, device approvals, and press announcements—with optional keyword matching. Its stated workflow runs an hourly poll, scores matches for significance and health impact, and emails summaries to subscribers. The page exposes a free tier with one unlocked notification per week and a Pro tier with real-time delivery. Pro users are also promised API access to notification history through GET /api/v1/notifications using an X-API-Key header.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible

⊠LoginAccess appeared gated

$PaidCommerce or pricing visible

✦PrettyNotable craft visible

●ProPolished or operationally mature

◎NicheUnusually specific use

One card from the complete issue

Paperwork for the Close-Up

294,223 arrived 1,000 judged 1000 catalogued Enter the complete issue